Katherine Littrell | Head of Investor Relations |
Bruce Cozadd | Chairman and Chief Executive Officer |
Matthew Young | Executive Vice President and Chief Financial Officer |
Michael Miller | Executive Vice President, US Commercial |
Jed Black | Senior Vice President, Sleep and CNS Medicine |
Allen Yang | Head of Clinical Development and Acting Chief Medical Officer |
Daniel Swisher | President and Chief Operating Officer |
Brandon Folkes | Cantor Fitzgerald |
Umer Raffat | Evercore ISI |
Jason Gerberry | Bank of America Merrill Lynch |
David Amsellem | Piper Jaffray |
Ami Fadia | SVB Leerink |
Gary Nachman | BMO Capital Markets |
David Risinger | Morgan Stanley |
Greg Fraser | SunTrust Robinson Humphrey |
Ken Cacciatore | Cowen and Company |
Jessica Fye | J.P. Morgan |
Liav Abraham | Citigroup |
Irina Koffler | Mizuho Securities |
Nick Rubino | Stifel Financial Corp. |
Akash Tewari | Wolfe Research, LLC |
David Maris | Wells Fargo |
Welcome to the Jazz Pharmaceuticals Plc First Quarter 2019 Earnings Conference Call.
Following an introduction from the company, we will open the call to questions. At this time, all participants are in a listen-only mode. [Operator Instructions].
As a reminder, this conference call is being recorded.